These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30578306)

  • 1. Induction of the BIM Short Splice Variant Sensitizes Proliferating NK Cells to IL-15 Withdrawal.
    Jacobs B; Pfefferle A; Clement D; Berg-Larsen A; Saetersmoen ML; Lorenz S; Wiiger MT; Goodridge JP; Malmberg KJ
    J Immunol; 2019 Feb; 202(3):736-746. PubMed ID: 30578306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional NK cell repertoires are maintained through IL-2Rα and Fas ligand.
    Felices M; Lenvik TR; Ankarlo DE; Foley B; Curtsinger J; Luo X; Blazar BR; Anderson SK; Miller JS
    J Immunol; 2014 Apr; 192(8):3889-97. PubMed ID: 24634493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.
    Huntington ND; Puthalakath H; Gunn P; Naik E; Michalak EM; Smyth MJ; Tabarias H; Degli-Esposti MA; Dewson G; Willis SN; Motoyama N; Huang DC; Nutt SL; Tarlinton DM; Strasser A
    Nat Immunol; 2007 Aug; 8(8):856-63. PubMed ID: 17618288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials.
    Törnroos H; Hägerstrand H; Lindqvist C
    Anticancer Res; 2019 Jan; 39(1):107-112. PubMed ID: 30591446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of cytokine-induced proliferation of human Natural Killer cells by intravenous immunoglobulin G.
    Issekutz AC; Derfalvi B; Käsermann F; Rowter D
    Clin Immunol; 2015 Dec; 161(2):373-83. PubMed ID: 26307433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells.
    Toka FN; Nfon CK; Dawson H; Estes DM; Golde WT
    J Interferon Cytokine Res; 2009 Mar; 29(3):179-92. PubMed ID: 19196070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.
    Mao Y; van Hoef V; Zhang X; Wennerberg E; Lorent J; Witt K; Masvidal L; Liang S; Murray S; Larsson O; Kiessling R; Lundqvist A
    Blood; 2016 Sep; 128(11):1475-89. PubMed ID: 27465917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells.
    Rodella L; Zamai L; Rezzani R; Artico M; Peri G; Falconi M; Facchini A; Pelusi G; Vitale M
    Br J Haematol; 2001 Nov; 115(2):442-50. PubMed ID: 11703348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.
    Cooper MA; Bush JE; Fehniger TA; VanDeusen JB; Waite RE; Liu Y; Aguila HL; Caligiuri MA
    Blood; 2002 Nov; 100(10):3633-8. PubMed ID: 12393617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function.
    Satwani P; van de Ven C; Ayello J; Cairo D; Simpson LL; Baxi L; Cairo MS
    Cytotherapy; 2011 Jul; 13(6):730-8. PubMed ID: 21413839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
    BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells.
    Phan MT; Lee SH; Kim SK; Cho D
    Methods Mol Biol; 2016; 1441():167-74. PubMed ID: 27177665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-7 enhances survival of human CD56bright NK cells.
    Michaud A; Dardari R; Charrier E; Cordeiro P; Herblot S; Duval M
    J Immunother; 2010 May; 33(4):382-90. PubMed ID: 20386468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.
    Laprevotte E; Voisin G; Ysebaert L; Klein C; Daugrois C; Laurent G; Fournie JJ; Quillet-Mary A
    J Immunol; 2013 Oct; 191(7):3634-40. PubMed ID: 23997218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Natural Killer Cells Proliferation by Cytokine Stimulation.
    Pencheva-Demireva M; El-Darawish Y; Kavaldzhieva K; Mladenov N; Lazarov V; Dimitrova-Dikanarova D; Markova T; Nikolov R; Okamura H
    Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):85-88. PubMed ID: 31009333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells.
    Shenoy AR; Kirschnek S; Häcker G
    Eur J Immunol; 2014 Aug; 44(8):2500-7. PubMed ID: 24825007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Uncoupling of Canonical Phenotypic Markers and Functional Potency of
    Lieberman NAP; DeGolier K; Haberthur K; Chinn H; Moyes KW; Bouchlaka MN; Walker KL; Capitini CM; Crane CA
    Front Immunol; 2018; 9():150. PubMed ID: 29456538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.